NO951110L - Farmasöytiske preparater med forlenget frigivelse av trimetazidin - Google Patents
Farmasöytiske preparater med forlenget frigivelse av trimetazidinInfo
- Publication number
- NO951110L NO951110L NO951110A NO951110A NO951110L NO 951110 L NO951110 L NO 951110L NO 951110 A NO951110 A NO 951110A NO 951110 A NO951110 A NO 951110A NO 951110 L NO951110 L NO 951110L
- Authority
- NO
- Norway
- Prior art keywords
- trimethazidine
- pharmaceutical preparations
- release pharmaceutical
- prolonged release
- liberation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9403434A FR2717687B1 (fr) | 1994-03-24 | 1994-03-24 | Compositions pharmaceutiques permettant la libération prolongée de trimétazidine après administration par voie orale. |
Publications (3)
Publication Number | Publication Date |
---|---|
NO951110D0 NO951110D0 (no) | 1995-03-23 |
NO951110L true NO951110L (no) | 1995-09-25 |
NO306450B1 NO306450B1 (no) | 1999-11-08 |
Family
ID=9461361
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO951110A NO306450B1 (no) | 1994-03-24 | 1995-03-23 | Farmasöytiske preparater med forlenget frigivelse av trimetazidin |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0673649B1 (no) |
JP (1) | JP3017040B2 (no) |
CN (1) | CN1056057C (no) |
AT (1) | ATE216583T1 (no) |
AU (1) | AU684893B2 (no) |
CA (1) | CA2145248C (no) |
DE (1) | DE69526467T2 (no) |
DK (1) | DK0673649T3 (no) |
ES (1) | ES2176296T3 (no) |
FI (1) | FI116881B (no) |
FR (1) | FR2717687B1 (no) |
NO (1) | NO306450B1 (no) |
NZ (1) | NZ270791A (no) |
PT (1) | PT673649E (no) |
ZA (1) | ZA952418B (no) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2802424B1 (fr) * | 1999-12-17 | 2002-02-15 | Adir | Comprime matriciel permettant la liberation prolongee de trimetazidine apres administration par voie orale |
EP1195160B1 (en) * | 2000-10-05 | 2009-09-16 | USV Ltd. | Sustained release trimetazidine pharmaceutical compositions and a method of their preparation |
FR2818549B1 (fr) * | 2000-12-26 | 2003-02-07 | Servier Lab | Composition pharmaceutique solide thermoformable pour la liberation controlee de trimetazidine |
EP1448173A2 (en) * | 2001-11-21 | 2004-08-25 | Themis Laboratories Private Limited | A process for manufacture of a sustained release pharmaceutical composition containing microbeads of trimetazidine dihydrochloride |
FR2885807B1 (fr) * | 2005-05-18 | 2008-05-16 | Mg Pharma | Composition pharmaceutique solide a liberation prolongee de 1-(2,3,4-trimethoxybenzyl) piperazine, et procede de preparation |
WO2007116243A2 (en) * | 2006-04-10 | 2007-10-18 | Mintails Limited | Method for treating fibromyalgia and related conditions |
EP2200591A2 (en) | 2007-09-11 | 2010-06-30 | Ranbaxy Laboratories Limited | Controlled release pharmaceutical dosage forms of trimetazidine |
EP2389167A2 (en) | 2009-01-20 | 2011-11-30 | Micro Labs Limited | Modified release solid pharmaceutical compositions of trimetazidine and process thereof |
EP2391353B1 (en) * | 2009-01-30 | 2016-02-10 | Lupin Limited | Pharmaceutical compositions of trimetazidine |
TR201001902A2 (tr) | 2010-03-12 | 2011-04-21 | Ali̇ Rai̇f İlaç Sanayi̇ Ve Ti̇caret A.Ş. | Uzatılmış salınımlı trimetazidin tablet |
US20110274751A1 (en) | 2010-05-04 | 2011-11-10 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Trimetazidine formulation with different release profiles |
EP2386302A1 (en) | 2010-05-11 | 2011-11-16 | Ranbaxy Laboratories Limited | A controlled release pharmaceutical dosage form of trimetazidine and processes for the preparation thereof |
BG1345U1 (bg) * | 2010-05-20 | 2010-08-31 | "Адифарм" Ад | Лекарствена форма с изменено освобождаване |
EP2491930A1 (en) | 2011-02-25 | 2012-08-29 | Deva Holding Anonim Sirketi | Pharmaceutical combination of betahistine and trimetazidine |
CN102133195A (zh) * | 2011-03-17 | 2011-07-27 | 王国栋 | 盐酸曲美他嗪的缓控释微丸及其制备方法 |
CN102319225B (zh) * | 2011-09-23 | 2013-04-03 | 广州白云山光华制药股份有限公司 | 一种盐酸曲美他嗪缓释片及其制备方法 |
FR2986431B1 (fr) * | 2012-02-03 | 2017-03-17 | Servier Lab | Composition pharmaceutique a liberation prolongee de trimetazidine, son procede de fabrication et son utilisation dans des traitements therapeutiques |
CN102764261A (zh) * | 2012-07-30 | 2012-11-07 | 沈阳药科大学 | 口服控制盐酸曲美他嗪释放的组合物及其制备方法 |
CN103565751A (zh) * | 2013-10-17 | 2014-02-12 | 广州帝奇医药技术有限公司 | 一种长效缓释微丸及其制备方法 |
US20190381034A1 (en) * | 2018-06-14 | 2019-12-19 | Ming Fang | Pharmaceutical composition and method for acute on chronic liver failure and related liver diseases |
CN110237053A (zh) * | 2019-07-26 | 2019-09-17 | 湖北欣泽霏药业有限公司 | 一种盐酸曲美他嗪缓释微丸及其制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2490963B1 (fr) * | 1980-09-30 | 1986-04-18 | Science Union & Cie | Nouvelle composition therapeutique a action anti-ischemique contenant de la trimethoxy 2, 3, 4-benzyl 1-piperazine |
DE3686275T2 (de) * | 1985-01-11 | 1993-03-18 | Teijin Ltd | Praeparate mit verzoegerter freisetzung. |
JPH0625055B2 (ja) * | 1985-03-18 | 1994-04-06 | 日本ケミフア株式会社 | 持続性錠剤 |
US5260066A (en) * | 1992-01-16 | 1993-11-09 | Srchem Incorporated | Cryogel bandage containing therapeutic agent |
US5417983A (en) * | 1992-02-19 | 1995-05-23 | Sagami Chemical Research Center | Drug release controlling material responsive to changes in temperature |
-
1994
- 1994-03-24 FR FR9403434A patent/FR2717687B1/fr not_active Expired - Fee Related
-
1995
- 1995-03-22 EP EP95400628A patent/EP0673649B1/fr not_active Expired - Lifetime
- 1995-03-22 FI FI951357A patent/FI116881B/fi not_active IP Right Cessation
- 1995-03-22 DK DK95400628T patent/DK0673649T3/da active
- 1995-03-22 ES ES95400628T patent/ES2176296T3/es not_active Expired - Lifetime
- 1995-03-22 DE DE69526467T patent/DE69526467T2/de not_active Expired - Lifetime
- 1995-03-22 AU AU15029/95A patent/AU684893B2/en not_active Expired
- 1995-03-22 PT PT95400628T patent/PT673649E/pt unknown
- 1995-03-22 CA CA002145248A patent/CA2145248C/fr not_active Expired - Lifetime
- 1995-03-22 AT AT95400628T patent/ATE216583T1/de active
- 1995-03-23 NZ NZ270791A patent/NZ270791A/xx not_active IP Right Cessation
- 1995-03-23 NO NO951110A patent/NO306450B1/no not_active IP Right Cessation
- 1995-03-24 ZA ZA952418A patent/ZA952418B/xx unknown
- 1995-03-24 JP JP7065788A patent/JP3017040B2/ja not_active Expired - Lifetime
- 1995-03-24 CN CN95103558A patent/CN1056057C/zh not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
FR2717687A1 (fr) | 1995-09-29 |
FI951357A (fi) | 1995-09-25 |
DE69526467D1 (de) | 2002-05-29 |
DK0673649T3 (da) | 2002-08-05 |
ES2176296T3 (es) | 2002-12-01 |
CN1056057C (zh) | 2000-09-06 |
CN1124140A (zh) | 1996-06-12 |
EP0673649A1 (fr) | 1995-09-27 |
CA2145248A1 (fr) | 1995-09-25 |
JP3017040B2 (ja) | 2000-03-06 |
AU1502995A (en) | 1995-10-05 |
ZA952418B (en) | 1995-12-18 |
DE69526467T2 (de) | 2002-12-05 |
PT673649E (pt) | 2002-08-30 |
AU684893B2 (en) | 1998-01-08 |
ATE216583T1 (de) | 2002-05-15 |
JPH07258086A (ja) | 1995-10-09 |
EP0673649B1 (fr) | 2002-04-24 |
NZ270791A (en) | 1996-07-26 |
FI116881B (fi) | 2006-03-31 |
FR2717687B1 (fr) | 1996-06-14 |
CA2145248C (fr) | 2004-01-06 |
FI951357A0 (fi) | 1995-03-22 |
NO951110D0 (no) | 1995-03-23 |
NO306450B1 (no) | 1999-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO951110L (no) | Farmasöytiske preparater med forlenget frigivelse av trimetazidin | |
DE68902344D1 (de) | Arzneimittel mit guter stabilitaet. | |
AU7534087A (en) | Sustained release pharmaceutical compositions in oral dosage form | |
DK0553890T3 (da) | Diphenylheteroalkylderivater, deres fremstilling og lægemidler og kosmetisk fremstillet derudfra | |
DE69015842D1 (de) | Nicotinsäurederivate und diese enthaltende pharmazeutische Zusammensetzungen. | |
DK0432117T3 (da) | Farmaceutisk præparat til behandling af inflammation | |
GB8903777D0 (en) | Shampoo composition | |
NO890062D0 (no) | 3,5-dihydrokarboksylsyrer og derivater derav samt fremgangsmaater for fremstilling av disse. | |
DK131887A (da) | 1,2,3,4-tetrahydro-3-carbamoyl-2-thioxo/oxo-5-pyrimidencarboxylsyre-derivater og deres anvendelse som laegemidler | |
KR900700425A (ko) | 2,3-디플루오로페놀 유도체 | |
AU544975B2 (en) | Oxazole derivatives | |
DE68913090D1 (de) | Modifizierter menschlicher PSTI. | |
DK474889A (da) | To-kammerpose til anvendelse som kunstig lunge | |
AU7191891A (en) | Water soluble salts of purpuromycin and pharmaceutical formulations thereof | |
DK37787A (da) | 2,3-dioxabicyclooe3,3,0aaoctan-derivater og deres anvendelse som laegemidler | |
DK62889A (da) | 1-aminomethyl-3-(2-flour-3-chlorphenyl)-4-cyanopyrrolderivater, fremgangsmaader til deres fremstilling samt deres anvendelse | |
NO163813C (no) | Forbindelser inneholdende perfluoralkylgrupper og anvendelse derav som avskummingsmiddel for vandige polymerdispersjoner. | |
ES1021790Y (es) | Modelo de calzado perfeccionado. | |
NO910903L (no) | Orale farmasoeytiske preparater med selektiv frigjoering i tykktarmen. | |
ES1012015Y (es) | Calzado infantil perfeccionado. | |
NO911580L (no) | 2-aminokarboksylsyrer og deres derivater, fremgangsmaate for fremstilling av disse og deres anvendelse som medikamenter. | |
ATE101618T1 (de) | Modifizierter menschlicher psti. | |
SE9002275D0 (sv) | Novel 3,3'-dithiobis(propionic acids) | |
ITRM940461A0 (it) | Doppio sistema di vaccino contro il cancro ed bivaccino a specifico eterologo, entrambi naturali non sofisticati, polivalenti, entrambi proposti insieme alla cosi' detta biolinfa per la cura e la prevenzione del cancro | |
ES1020578Y (es) | Calzado de seguridad perfeccionado. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1K | Patent expired |